KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Align Technology (ALGN) Research & Development (2016 - 2025)

Align Technology (ALGN) has disclosed Research & Development for 17 consecutive years, with $83.0 million as the latest value for Q4 2025.

  • Quarterly Research & Development fell 12.48% to $83.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $369.9 million through Dec 2025, up 1.57% year-over-year, with the annual reading at $369.9 million for FY2025, 1.57% up from the prior year.
  • Research & Development for Q4 2025 was $83.0 million at Align Technology, down from $93.3 million in the prior quarter.
  • The five-year high for Research & Development was $97.2 million in Q1 2025, with the low at $54.5 million in Q1 2021.
  • Average Research & Development over 5 years is $81.8 million, with a median of $84.4 million recorded in 2022.
  • The sharpest move saw Research & Development skyrocketed 48.25% in 2021, then decreased 12.48% in 2025.
  • Over 5 years, Research & Development stood at $72.5 million in 2021, then increased by 15.24% to $83.5 million in 2022, then fell by 1.63% to $82.2 million in 2023, then rose by 15.48% to $94.9 million in 2024, then dropped by 12.48% to $83.0 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $83.0 million, $93.3 million, and $96.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.